Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Deciphera Pharmaceuticals, Inc. (DCPH)  
$25.36 0.01 (0.04%) as of 4:30 Fri 5/10


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 60,930,000
Market Cap: 1.55(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $10.11 - $25.38
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Deciphera Pharmaceuticals is a biopharmaceutical company focused on discovering, developing, and commercializing medicines to improve the lives of people with cancer. QINLOCK, Co.'s switch-control kinase inhibitor, was developed using Co.'s proprietary drug discovery platform and developed for the treatment of fourth-line gastrointestinal stromal tumor. In addition, Co. has identified and developed various product candidates from its platform into clinical studies, including vimseltinib and DCC-3116. Co. is studying vimseltinib in a Phase 3 study in patients with tenosynovial giant cell tumor. DCC-3116 is designed to inhibit autophagy, a key tumor survival mechanism in cancer cells.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 10,000 1,687,666
Total Buy Value $0 $0 $138,828 $30,291,232
Total People Bought 0 0 1 3
Total Buy Transactions 0 0 1 3
Total Shares Sold 10,159 75,715 115,161 179,650
Total Sell Value $158,659 $1,108,986 $1,602,723 $2,646,007
Total People Sold 4 5 6 6
Total Sell Transactions 4 14 25 43
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 290
  Page 6 of 12  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Kelly Thomas Patrick Chief Financial Officer   •       –      –    2020-09-14 4 AS $50.01 $150,036 D/D (3,000) 7,040 -8%     
   Kelly Thomas Patrick Chief Financial Officer   •       –      –    2020-09-14 4 OE $1.89 $5,670 D/D 3,000 10,040     -
   Kelly Thomas Patrick Chief Financial Officer   •       –      –    2020-09-10 4 AS $47.71 $143,126 D/D (3,000) 7,040 6%     
   Kelly Thomas Patrick Chief Financial Officer   •       –      –    2020-09-10 4 OE $1.89 $5,670 D/D 3,000 10,040     -
   Kelly Thomas Patrick Chief Financial Officer   •       –      –    2020-09-08 4 AS $44.69 $272,929 D/D (6,000) 7,040 9%     
   Kelly Thomas Patrick Chief Financial Officer   •       –      –    2020-09-08 4 OE $1.89 $11,340 D/D 6,000 13,040     -
   Hoerter Steven L. President and CEO   •       •      –    2020-08-20 4 OE $25.40 $4,750 D/D 187 42,767     -
   Flynn Daniel Lee Chief Scientific Officer   •       –      –    2020-08-10 4 OE $1.89 $17,065 D/D 9,029 237,475     -
   Flynn Daniel Lee Chief Scientific Officer   •       –      –    2020-07-22 4 OE $1.89 $245,700 D/D 130,000 228,446     -
   Hoerter Steven L. President and CEO   •       •      –    2020-07-20 4 OE $25.40 $4,775 D/D 188 42,580     -
   Taylor Michael Douglas Director   –       •      –    2020-07-06 4 AS $54.69 $1,520,873 D/D (27,544) 0 18%     
   Taylor Michael Douglas Director   –       •      –    2020-07-06 4 OE $1.89 $52,058 D/D 27,544 27,544     -
   Taylor Michael Douglas Director   –       •      –    2020-07-02 4 AS $56.01 $2,734,965 D/D (48,245) 0 15%     
   Taylor Michael Douglas Director   –       •      –    2020-07-02 4 OE $1.89 $91,183 D/D 48,245 48,245     -
   Taylor Michael Douglas Director   –       •      –    2020-07-01 4 AS $58.22 $2,896,889 D/D (49,211) 0 12%     
   Taylor Michael Douglas Director   –       •      –    2020-07-01 4 OE $1.89 $93,009 D/D 49,211 49,211     -
   Hoerter Steven L. President and CEO   •       •      –    2020-06-18 4 OE $25.40 $4,750 D/D 187 42,392     -
   Allen Patricia L Director   –       •      –    2020-06-05 4 S $55.90 $314,999 D/D (5,635) 0 -7%     
   Allen Patricia L Director   –       •      –    2020-06-05 4 OE $25.73 $144,989 D/D 5,635 5,635     -
   Allen Patricia L Director   –       •      –    2020-06-03 4 S $59.14 $376,450 D/D (6,365) 0 1%     
   Allen Patricia L Director   –       •      –    2020-06-03 4 OE $25.73 $163,771 D/D 6,365 6,365     -
   Hoerter Steven L. President and CEO   •       •      –    2020-05-28 4 OE $25.40 $4,775 D/D 188 42,205     -
   Kelly Thomas Patrick Chief Financial Officer   •       –      –    2020-05-11 4 AS $55.08 $662,240 D/D (12,000) 7,040 -6%     
   Kelly Thomas Patrick Chief Financial Officer   •       –      –    2020-05-11 4 OE $1.89 $22,680 D/D 12,000 19,040     -
   Taylor Michael Douglas Director   –       •      –    2020-04-28 4 AS $55.12 $1,422,490 D/D (25,000) 0 -5%     
  290 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 6 of 12
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us